• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

jennifer.juno@unimelb.edu.au

Credentials


Position
Principal Research Fellow
Department of Microbiology and Immunology
Education
PhD
University of Manitoba
Bachelors Degree (Honours)
University of Toronto
ORCID

0000-0002-9072-1017

A/Prof Jennifer Juno

Principal Research Fellow
Department of Microbiology and Immunology

131 Scholarly works
15 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Immune responses associated with protection from SARS-CoV-2 infection
    DOI: 10.1016/j.vaccine.2026.128579
  • 2026

    Journal article

    Age-related differences in mRNA vaccine immunogenicity and adjuvancy
    DOI: 10.1111/imcb.70102
  • 2026

    Journal article

    Evaluating southern pigtail macaques as an immunological model for human antibody responses.
    DOI: 10.1038/s41598-026-42695-6
  • 2024

    Research grants (other domestic)

    Improving Vaccine Efficacy by Maximising T Cell Help
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    Immune Responses to SARS-CoV-2 Variants Across Age Groups and Vulnerable Populations
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    Harnessing T Cell Immunity to Boost Vaccine Efficacy
  • 2021

    Journal article

    Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences
    DOI: 10.1183/13993003.03730-2020
Jennifer Juno

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality
    DOI: 10.1016/j.ebiom.2026.106185
  • 2026

    Journal article

    Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses
    DOI: 10.1016/j.ebiom.2025.106087
  • 2026

    Journal article

    Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults
    DOI: 10.3390/vaccines14010028
  • 2025

    Journal article

    Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
    DOI: 10.1038/s44298-025-00116-x
  • 2025

    Journal article

    T follicular helper cell differentiation programs immunogenicity of prototypic influenza vaccines 4602
    DOI: 10.1093/jimmun/vkaf283.2264
  • 2025

    Journal article

    Chimeric coronavirus spike combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent T helper cell and neutralising antibody responses in murine and non-human primate models 4642
    DOI: 10.1093/jimmun/vkaf283.2295
  • 2025

    Journal article

    Divergent cytokine and transcriptional signatures control functional T follicular helper cell heterogeneity
    DOI: 10.1038/s41590-025-02258-9

RECENT PROJECTS

  • 2023

    Research grants (other domestic)

    Monoclonal Antibodies to Treat and Prevent Orthopoxvirus and Henipavirus Pandemic Threats

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224